Please login to the form below

Not currently logged in
Email:
Password:

Kengreal

This page shows the latest Kengreal news and features for those working in and with pharma, biotech and healthcare.

FDA gives the nod to TMC's antiplatelet drug

FDA gives the nod to TMC's antiplatelet drug

Kengreal approved in the US three months after it got the green light in Europe. ... The Medicines Company (TMC) has finally won US approval for its injectable antiplatelet drug Kengreal for the prevention of blood clots during heart procedures.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...
Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...

Infographics